Your source for ophthalmic news
Eyewire+ (eyewire.news) scores 68 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Media & Entertainment brands, in the 19th percentile of 22360 Healthcare brands.
Eyewire+ (eyewire.news) is a media platform serving the ophthalmic and eye care industry. It delivers breaking ophthalmic news, device and drug updates, clinical trial coverage, and thought-leader perspectives through articles, podcasts, and TV segments. The platform targets ophthalmologists, optometrists, and other eye care professionals and industry decision-makers seeking timely information on developments in eye care devices, pharmaceuticals, and clinical research.
| Brand Name | Eyewire+ |
|---|---|
| Domain | eyewire.news |
| Industry | Healthcare, Media & Entertainment |
| Main Competitors | Ophthalmology Times (77/100), Healio Ophthalmology (86/100), Modern Retina (70/100), EyeWorld (78/100), Review of Ophthalmology (65/100), Optometry Times (80/100), MedPage Today (88/100) |
Ranked #1,154,340 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
Eyewire+ appears on Wikipedia but without a dedicated company entity, so AI models can confuse it with similarly named subjects.
The homepage meta description reads "Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements." (Meta description: 16 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt mentions GPTBot, ChatGPT-User, Google-Extended - all allowed - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, YouTube, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is Eyewire+?", Claude could not identify the brand as of November 2026. I don't recognize 'Eyewire+' at eyewire.news as a specific healthcare company, possibly because it's a small, niche, or newly launched outlet with limited web presence under that exact name.
When asked "Best brands similar to Eyewire+?", Claude would not surface Eyewire+ as of November 2026. I can't vouch for or recommend a company I can't verify any details about.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Eyewire+'s main competitors in Healthcare: Ophthalmology Times (77/100), Healio Ophthalmology (86/100), Modern Retina (70/100), EyeWorld (78/100), Review of Ophthalmology (65/100).
Sources: Brand Analyzer scan
Eyewire+ has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 35, trust 15, recommendation 54). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Eyewire+ official site
Eyewire+ offers ophthalmic news coverage, clinical trial updates, device and drug announcements, and thought-leader commentary. Content is distributed through articles, podcasts, and TV-style video segments tailored to the eye care industry.
Sources: Eyewire+ official site
Eyewire+ scores 54/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: Eyewire+ official site
Eyewire+ is an online media platform and news source focused on the ophthalmic and eye care industry. It aggregates breaking news, device and drug updates, clinical trial coverage, and thought-leader commentary for eye care professionals.
Sources: Eyewire+ official site
Eyewire+ delivers ophthalmic industry news, including updates on new devices, drugs, and clinical trials, along with expert commentary and perspectives. It presents this content through multiple formats such as written articles, podcasts, and TV-style video segments aimed at keeping eye care professionals informed of industry developments.
Sources: Eyewire+ official site
Eyewire+ can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Eyewire+ official site
Eyewire+ is used by ophthalmologists, optometrists, eye care industry professionals, and healthcare decision-makers who seek up-to-date information on ophthalmic news, device and drug developments, and clinical trial results.
Sources: Eyewire+ official site
Eyewire+ is known for aggregating timely ophthalmic industry news, including clinical trial results, device and drug updates, and commentary from thought leaders in eye care, often presented through multimedia formats like podcasts and video segments.
Sources: Eyewire+ official site
Eyewire+ scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Eyewire+ has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (54/100) and its weakest is trust (15/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,154,340 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check (November 2026), Claude could not identify Eyewire+ from memory, confirming the gaps above.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Eyewire+: Evergreen Lifestyle (68/100), Evans Senior Investments (68/100), ELEHEAR (68/100), Faircape Group (68/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.